Bgm (BGM) EPS (Basic) (2024 - 2025)
Bgm (BGM) posted quarterly EPS (Basic) of $5.76 for Q1 2025, down 2.61% quarter-over-quarter from $5.91 in Q3 2024.
Bgm (BGM) EPS (Basic) (2024 - 2025) Analysis & Trends
Bgm (BGM) has reported EPS (Basic) for 2 consecutive years, with $5.76 the latest figure, recorded in Q1 2025.
- In Q1 2025, EPS (Basic) changed N/A year-over-year to $5.76; the TTM figure through Sep 2025 stood at $1.99 (down 66.43% YoY), while the FY2025 annual figure was -$0.18, up 11.82% from the prior year.
- EPS (Basic) declined to $5.76 in Q1 2025 per BGM's latest filing, from $5.91 in the prior quarter.
- Across five years, EPS (Basic) topped out at $5.91 in Q3 2024 and bottomed at $5.76 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Bgm | 29.89 Mn | 20.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 5.76 |
| Sep 30, 2024 | 5.91 |